Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive He...
Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
Despite angiotensin-converting enzyme (ACE) inhibition is a very powerful therapy, it may not be uniformly renoprotective in patients with proteinuric nephropathies who might refer late in the course of the disease. In accelerated...
Alternative Titles
Full title
Combining lisinopril and L-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_73483507
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_73483507
Other Identifiers
ISSN
0085-2538
E-ISSN
1523-1755
DOI
10.1046/j.1523-1755.2003.00191.x
